Jagsonpal Pharma acquires 77.21% stake in Aequitas Healthcare

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹228.80

prior close

₹231.66

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.9%-0.7% vs market

Pharmaceuticals peers, median of 166sector+0.9%+0.3% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

+0.0

15m

+1.2

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2+1.9-0.7+0.9+0.3

Next day

+1.8+3.3-1.5+1.4+0.5

+0.3+3.5-3.1+1.8-1.4

-1.5+2.4-4.0+1.4-2.9

-1.6+3.1-4.7+1.6-3.2

-1.5+2.6-4.1+1.6-3.0

-2.5+2.1-4.7+1.2-3.8

15d

+1.6+0.9+0.7-0.6+2.3

+2.3+5.5-3.2+0.6+1.7

+2.3+8.1-5.8+2.7-0.4

-1.3+3.5-4.8-0.8-0.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jagsonpal Pharmaceuticals has completed the acquisition of 77.21% equity stake in Aequitas Healthcare Private Limited, falling short of the initially proposed 85% stake. The deal was previously disclosed in letters to the exchanges dated 29 June and 7 July 2026. The acquisition marks a strategic expansion of the company into the healthcare services space through majority ownership.

Likely market impact

Strengthens Jagsonpal's healthcare portfolio via majority ownership of Aequitas, though the final stake is slightly below the initially announced 85% target.